Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03205605 · ClinicalTrials.gov registry record · Early Phase 1
Effect of Heat on Oxybutynin Release and Absorption From Oxybutynin Products
A Early Phase 1 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 13
- Enrollment target
NCT03205605 is a Early Phase 1 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 13 participants.
The verdict
NCT03205605, a Early Phase 1 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
This research study is intended to determine the effect of heat and occlusion on oxybutynin products.
Interventions
- DRUG oxybutynin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2018-01-02 |
| Est. Completion | 2019-11-13 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03205605
The ClinicalTrials.gov registry entry for NCT03205605 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which oxybutynin is the first listed.
NCT03205605 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03205605 about?
NCT03205605 is a clinical study titled "Effect of Heat on Oxybutynin Release and Absorption From Oxybutynin Products". This research study is intended to determine the effect of heat and occlusion on oxybutynin products.
What is the current status of trial NCT03205605?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 13 participants. The study started on 2018-01-02. Estimated completion is 2019-11-13.
What interventions are being tested in trial NCT03205605?
The interventions under investigation include: oxybutynin (DRUG).
Who is sponsoring clinical trial NCT03205605?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.